Page 20 - Viral Vector News Today

New approach could treat infertility caused by abnormal GnRH secretion Reports suggest that at least 25% of ovarian disorders are due to dysfunction of the brain mechanism in the hypothalamus that controls the gonadotropin-releasing hormone (GnRH), which is a molecule that governs the reproductive function in men and women by regulating the release of a range of reproductive hormones into the body, particularly gonadotropins, from the pituitary gland, which is located underneath the brain. In a...

Delayed second dose strategy with mRNA vaccines may reduce COVID-19 mortality, say researchers An interesting new preprint on the medRxiv* server shows that even if countries are forced to delay the second dose of the current vaccines administered against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), to arrest the ongoing coronavirus disease 2019 (COVID-19) pandemic, the cumulative mortality would still fall significantly. The study aimed to provide an in-silico estimation ...

Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies, today announced the signing of a master research agreement with the Center for Innovation in Advanced Development and Manufacturing (CIADM) at Texas A&M University Health Science Center (TAMHSC). The agreement covers joint research and development projects for plasmid, protein and viral vector products in com...

The single dose vaccine was given the clear by the U.S. Food and Drug Administration for use by people 18 or older on Feb. 27.

Cédric Szpirer, Founder and Executive Director of Delphi Genetics, added, “The complementary activities and adjacent technologies will provide our customers, our employees, and ultimately patients around the world with a solid foundation for new therapeutic solutions in the cell and gene therapy domain.” Upon completion, all of Delphi’s highly skilled team, including R&D and genetic engineering scientists and technicians, regulatory specialists, and other associated roles will transfer t...

New study by the IBMCP of the UPV university facilitates the use of the CRISPR genomic editing technique on plants.

(North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at  US$ 76.4 million in 2018 and is expected to exhibit a CAGR of 25.0% over the forecast period (2019-2027),  as highlighted in a new report published by Coherent Market Insights. The increasing focus of market players on developing innovative techniques in order enhance the characterization of viral vectors are expected to drive growth of the viral vector and plasmid DNA testing services market over t...

50-year-old doctor becomes first healthcare worker in country to get the jab; says he is in "good health".

Share this article Share this article NOIDA, India, Jan. 29, 2021 /PRNewswire/ -- A comprehensive overview of the gene therapy market is recently added by UnivDatos Market Insights to its humongous database. The gene therapy market report has been aggregated by collecting informative data of various dynamics such as market drivers, restraints, and opportunities. This innovative report makes use of several analyses to get a closer outlook on the gene therapy market. The gene therapy market repor...

Viral Vector Manufacturing Market 2020 Analysis, Opportunities And Forecast To 2023